Get started
Author

Zhigang Feng

TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages
2023 · Jingjing Huang, Huayang Pan, et al. · Journal of Experimental & Clinical Cancer Research · 88
PDF
NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
2022 · Shounan Lu, Shanjia Ke, et al. · Oncogenesis · 35
PDF
RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway
2023 · Zhigang Feng, Shanjia Ke, et al. · Oncogene · 29
GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination
2025 · Hongjun Yu, Chaoqun Wang, et al. · Journal of Hepatology · 28
HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway
2023 · Yanan Xu, Shanjia Ke, et al. · Oncogenesis · 23
PDF
LncRNA Hnf4αos exacerbates liver ischemia/reperfusion injury in mice via Hnf4αos/Hnf4α duplex-mediated PGC1α suppression
2022 · Chaoqun Wang, Hongjun Yu, et al. · Redox Biology · 22
IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18 / STAT3 pathway
2024 · Menghua Zhou, Hongjun Yu, et al. · Cancer Science · 18
PDF
RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma
2024 · Shanjia Ke, Shounan Lu, et al. · Experimental & Molecular Medicine · 14
Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
2022 · Hongjun Yu, Chaoqun Wang, et al. · Frontiers in Immunology · 14
PDF
NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis
2025 · Bing Yin, Baolin Qian, et al. · Nature Communications · 13
PDF
Serum amyloid A‐to‐albumin ratio as a potential biomarker to predict the activity, severity, and poor prognosis of systemic lupus erythematosus
2022 · Liang Zhao, Qun Zhang, et al. · Journal of Clinical Laboratory Analysis · 12
PDF
An integrative pan-cancer analysis of MASP1 and the potential clinical implications for the tumor immune microenvironment
2024 · Hongjun Yu, Chaoqun Wang, et al. · International Journal of Biological Macromolecules · 10
Comprehensive analysis of transcriptome‐wide M 6 A methylation for hepatic ischaemia reperfusion injury in mice
2023 · yongliang hua, xinglong Li, et al. · Epigenetics · 9
Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression
2021 · Meng Wang, Zhigang Feng, et al. · Molecular and Cellular Biochemistry · 9
Arsenic trioxide preconditioning attenuates hepatic ischemia- reperfusion injury in mice: Role of ERK/AKT and autophagy
2025 · Chaoqun Wang, Hongjun Yu, et al. · Chinese Medical Journal · 5
Cancer‐Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT‐ANGPTL4 Axis
2026 · Shounan Lu, Shanjia Ke, et al. · Advanced Science · 3
A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: an analysis of the SEER database
2025 · Fei Wang, Xihao Wang, et al. · Frontiers in Immunology · 3
PDF
Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
2022 · Shanjia Ke, Shounan Lu, et al. · Frontiers in Molecular Biosciences · 3
Identification and validation of ferroptosis-related hub genes and immune infiltration in liver ischemia-reperfusion injury
2024 · Xinglong Li, Zhanzhi Meng, et al. · Genomics · 1
The effect of rheumatoid factor on three commercial immunoassays for serum cystatin C
2021 · Qun Zhang, Zhigang Feng, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 1
PDF
Tp53/HIF1α co-synergistically promotes CRMP4 expression via promoter-proximal interactions in colorectal cancer
2026 · Liang Chen, Yifen Shen, et al. · Communications Biology
PDF
RGS16 Aggravates Hepatic Ischemia‐Reperfusion Injury via Hepatocyte‐Intrinsic Apoptosis/Inflammation & Neutrophil Recruitment/NETosis
2026 · Xinglong Li, Zhanzhi Meng, et al. · Advanced Science
Abstract LB431: Discovery and characterization of a highly potent and orally available small-molecule inhibitor for diverse KRAS mutations
2025 · Yongxian Zhang, Fei Yang, et al. · Cancer Research
Effective Components and Molecular Mechanism of Biejiaruangan Capsule Against Liver Fibrosis: High-resolution Mass Spectrometry, Network Pharmacological Analysis and Experimental Verification
2024 · Kefeng Cao, Hui Jiang, et al. · Combinatorial Chemistry & High Throughput Screening
Abstract 2039: Cellular characterization of small molecule PD-L1 inhibitors reveal their novel mechanisms of action
2024 · Weiling Pan, Yongxian Zhang, et al. · Cancer Research
Works count: 36
Citation count: 340
H-index: 11
I10-index: 12
Year
Topic
Type